Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
25-27 August, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Not Confirmed
Not Confirmed
27-28 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
25-27 August, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Industry Trade Show
Not Confirmed
27-28 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
20 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250818666368/en/Evolus-Announces-Submission-of-Premarket-Approval-Application-to-the-U.S.-Food-and-Drug-Administration-for-Evolysse-Sculpt-Injectable-Hyaluronic-Acid-Gel-Product
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731065932/en/Evolus-Announces-Publication-of-Independent-Study-in-JAMA-Dermatology-Demonstrating-Jeuveau-as-a-Top-Performer-Among-Leading-Neurotoxins
22 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250722230366/en/Evolus-to-Report-Second-Quarter-Financial-Results-on-August-5-2025
11 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250711135929/en/Evolus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
09 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250709255697/en/Evolus-Expands-Global-Footprint-with-Introduction-of-Nuceiva-botulinum-toxin-type-A-in-France
13 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250613751303/en/Evolus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
ABOUT THIS PAGE